2. INTRODUCTION
⢠Androgen deprivation therapy (ADT), also called androgen
suppression therapy, is an antihormone therapy whose main use
in treating prostate cancer
⢠ADT reduces the level of androgen hormones, to prevent the
prostate cancer cells from growing
3. INDICATION
⢠High risk and Very High Risk Prostate Cancer
⢠Metastatic Prostate Cancer
⢠In recurrence after RT or Surgery
⢠Most patients with T3 are, at the present
time, treated with neoadjuvant hormonal
therapy followed by RT
4. Risiko Usia
>80 tahun 71-80 tahun ⤠70 tahun
Tinggi :
â˘T: 2b, 3a, 3b atau
â˘Gleason : âĽ4+3 atau
â˘PSA: 10-20 atau
â˘Temuan biopsi :
>50% perineural,
duktal
1. Terapi hormonal
2. EBRT + terapi
hormonal
3. Terapi
investigasional
1. ERBT + terapi
hormonal (2-3
tahun)
2. Terapi hormonal
3. Prostatektomi
radikal + diseksi
KGB pelvis
4. Terapi
investigasional
1. ERBT + terapi
hormonal (2-3
tahun)
2. Prostatektomi
radikal + diseksi
KGB pelvis
3. Terapi
investigasional
4. Terapi hormonal
Sangat tinggi:
â˘T: 4 atau
â˘Gleason : âĽ8 atau
â˘PSA: >20 dan
â˘Temuan biopsi :
limfovaskuler,
neuroendokrin
1. Terapi hormonal
2. ERBT + terapi
hormonal
3. Terapi
investigasional
1. Terapi hormonal
2. ERBT + terapi
hormonal
3. Sistemik terapi
non hormonal
(kemoterapi)
1. ERBT + terapi
hormonal
2. Terapi hormonal
3. Terapi sistemik
dan terapi
hormonal
4. Terapi multimodal
investigasional
Tabel 1. Penatalaksanaan kanker terlokalisir atau locally advanced.1
5. ANDROGEN DEPRIVATION THERAPY
⢠Androgen Deprivation Therapy :
â Medical
â Surgical (Orchidectomy) ; Simple or Subcapsullar
⢠The goal is Castration ; testosteron < 50ng/dl
⢠Strategy :
â Blokade :
⢠Complete Androgen Blokade (CAB) ; LHRH Agonist+ AA
⢠Single Androgen Blokade
â Timing : Continuous and Intermiten
â Time to Start : Immediate and Deferred
6. MECHANISMS OF ANDROGEN
AXIS BLOCKADE
1. Inhibition of LH-RH and/or LH release
2. Ablation of androgen sources
3. Inhibition androgen synthesis
4. Anti androgens
Bultitude MF. CampbellâWalsh Urology
Tenth Edition. Bju International.
2012;109(3).
8. 1. Inhibition of LH-RH and/or LH release
⢠LH-RH Agonists
- Desensitization of LH-RH receptors in the anterior
pituitary after chronic exposure to LH-RH, thereby
shutting down the production of LH and, ultimately,
testosterone decrease
- Cause Flare-upâ phenomenon
⢠LH-RH Antagonists
Bind immediately and competitively to the LH-RH
receptors in the pituitary, reducing LH concentrations
by 84% within 24 hours of administration
9. 2. Ablation of androgen sources
⢠Bilateral orchiectomy quickly reduces circulating
testosterone levels to less than 50 ng/dL
⢠Subcapsular Orchidectomy Bilateral (SOB)
advocated as a technique of ADT that avoids the
psychologic consequences of an empty scrotum
(Desmond et al, 1988)
⢠Quickest way to achieve castration level <12 hours
10. 3. Anti- androgens
⢠STEROID :
- Classic steroidal antiandrogen with direct AR blocking effects
- Rapidly lowers testosterone levels to 70% to 80% through its progestational
central inhibition
- Side effects are cardiovascular toxicity (4-40% for cyproterone acetate [CPA])
and hepatotoxicity.
⢠NON STEROID
- Blocking the testosterone feedback centrally
- libido, overall physical performance, and bone mineral density (BMD)
frequently preserved
- Bicalutamide showing a more favourable safety and tolerability profile than
flutamide and nilutamide
11. ⢠Abiraterone
- Significantly decreases the intracellular testosteron level by
suppressing the synthesis at adrenal level and inside the
cancer cells
- Inhibits several cytochrome P pathways, as a potent,
selective and irreversible inhibitor of cytochrome P17, a
key enzyme in androgen synthesis
4. Inhibition androgen synthesis (2)
12. 4. Inhibiting androgen synthesis
⢠Aminoglutethimide
Inhibition of a very proximal step in adrenal function,
aminoglutethimide blocks production of aldosterone
and cortisol
Medical Version of Adrenalectomy
⢠Ketoconazole
Demonstrated loss of adrenal steroid synthesis and
testosterone synthesis by Leydig cells